)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Spero Therapeutics
Spero Therapeutics (SPRO) investor relations material
Spero Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary27 Apr, 2026
Voting matters and shareholder proposals
Election of two Class III directors, Milind Deshpande, Ph.D., and Kathleen Tregoning, to serve until the 2029 Annual Meeting or until successors are elected and qualified.
Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
Advisory vote to approve the compensation of named executive officers as disclosed in the proxy statement.
Approval of an amendment to increase authorized common stock from 120,000,000 to 240,000,000 shares.
Approval of the 2026 Stock Incentive Plan and transaction of other properly presented business.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director elections and governance changes.
Executive compensation and say-on-pay
Advisory vote on executive compensation is included as a key agenda item for shareholder approval.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Spero Therapeutics
- Stockholders will vote on director elections, auditor ratification, compensation, share increase, and new incentives.SPRO
Proxy filing27 Apr 2026 - Stockholders will vote on director elections, auditor ratification, compensation, share increase, and new incentives.SPROProxy filing13 Apr 2026
- Returned to profitability in 2025, driven by collaboration revenue and milestone payments.SPROQ4 202526 Mar 2026
- Q2 net loss was $17.9M as R&D spending rose; cash runway extends into late 2025.SPROQ2 20242 Feb 2026
- SPR720 nears pivotal data for NTM-PD, while Tebipenem HBr advances in phase III with GSK.SPROH.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
- Advancing late-stage anti-infective therapies with major data and regulatory milestones ahead.SPRO2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
- Tebipenem HBr phase III interim analysis set for Q2 2025; cash runway into Q2 2026.SPROQ4 202424 Dec 2025
- Lead oral carbapenem asset nears phase III completion, with major milestones expected this year.SPROTD Cowen 45th Annual Healthcare Conference16 Dec 2025
- Stockholders to vote on director elections, auditor, executive pay, and stock plan amendment.SPROProxy Filing2 Dec 2025
Next Spero Therapeutics earnings date
Q1 202613 May, 2026
Spero Therapeutics
Next Spero Therapeutics earnings date
Q1 202613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage